Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: REACTION BIOLOGY CORPORATION
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2021-12-07 to 2022-12-06
Current total value of award: $166500
Description: TESTING OF COMPOUNDS FOR INHIBITION OF 370 WILD-TYPE KINASE ENZYMES